drugset / Trial / NCT00784810

A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis

NCT00784810

Phase 4 Completed 247 enrolled Napp Pharmaceuticals Limited
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare oxycodone/naloxone combination tablet and codeine/paracetamol tablets in the treatment of moderate to severe chronic low back pain or pain due to osteoarthritis.

Timeline

Start
2009-02
Primary completion
2010-03
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 500 mg
Comparator Codeine Small molecule 15 mg
Comparator Codeine Small molecule 30 mg
Subject Naloxone Small molecule 2.5 mg
Subject Naloxone Small molecule 5 mg
Subject Naloxone Small molecule 10 mg
Subject Oxycodone Other / unclassified 5 mg
Subject Oxycodone Other / unclassified 10 mg
Subject Oxycodone Other / unclassified 20 mg

Indications